ALSERES PHARMACEUTICALS INC /DE Preferred Stock Conversions, Inducements
ALSERES PHARMACEUTICALS INC /DE reported Preferred Stock Conversions, Inducements of $8.06 million for the 254-month period ending 2013-12-31, per its 10-K filed 2014-04-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockConversionsInducements · last filed 2014-04-10
- 2013-12-31: .
- 2013-09-30: .
- 2013-06-30: .
- 2013-03-31: .
| Period end | Preferred Stock Conversions, Inducements 224 month | Preferred Stock Conversions, Inducements 227 month | Preferred Stock Conversions, Inducements 230 month | Preferred Stock Conversions, Inducements 233 month | Preferred Stock Conversions, Inducements 236 month | Preferred Stock Conversions, Inducements 239 month | Preferred Stock Conversions, Inducements 242 month | Preferred Stock Conversions, Inducements 245 month | Preferred Stock Conversions, Inducements 248 month | Preferred Stock Conversions, Inducements 251 month | Preferred Stock Conversions, Inducements 254 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $8.06M 10-K · filed 2014-04-10 | ||||||||||
| 2013-09-30 | $8.06M 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | $8.06M 10-Q · filed 2013-08-09 | ||||||||||
| 2013-03-31 | $8.06M 10-Q · filed 2013-05-17 | ||||||||||
| 2012-12-31 | $8.06M 10-K · filed 2013-04-01 | ||||||||||
| 2012-09-30 | $8.06M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $8.06M 10-Q · filed 2012-08-13 | ||||||||||
| 2012-03-31 | -$8.06M 10-Q · filed 2012-05-11 | ||||||||||
| 2011-12-31 | $8.06M 10-K · filed 2012-03-29 | ||||||||||
| 2011-09-30 | $8.06M 10-Q · filed 2011-11-10 | ||||||||||
| 2011-06-30 | $8.06M 10-Q · filed 2011-08-11 |